These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37202895)

  • 41. In vitro and in silico analysis of novel astaxanthin-s-allyl cysteine as an inhibitor of butyrylcholinesterase and various globular forms of acetylcholinesterases.
    Sakayanathan P; Loganathan C; Kandasamy S; Ramanna RV; Poomani K; Thayumanavan P
    Int J Biol Macromol; 2019 Nov; 140():1147-1157. PubMed ID: 31442505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of some new N-(alkyl/aralkyl)-N-(2,3-dihydro-1,4-benzodioxan-6-yl)-4-chlorobenzenesulfonamides as possible therapeutic agents for Alzheimer's disease and Type-2 Diabetes.
    Abbasi MA; Rehman A; Siddiqui SZ; Hadi N; Mumtaz A; Shah SAA; Ashraf M; Abbasi GH
    Pak J Pharm Sci; 2019 Jan; 32(1):61-68. PubMed ID: 30772791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibitors.
    Burmaoglu S; Yilmaz AO; Polat MF; Kaya R; Gulcin İ; Algul O
    Bioorg Chem; 2019 Apr; 85():191-197. PubMed ID: 30622011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, characterization, evaluation of metabolic enzyme inhibitors and in silico studies of thymol based 2-amino thiol and sulfonic acid compounds.
    Bora RE; Genc Bilgicli H; Üç EM; Alagöz MA; Zengin M; Gulcin İ
    Chem Biol Interact; 2022 Oct; 366():110134. PubMed ID: 36057360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biologically active phthalocyanine metal complexes: Preparation, evaluation of α-glycosidase and anticholinesterase enzyme inhibition activities, and molecular docking studies.
    Güzel E; Koçyiğit ÜM; Taslimi P; Erkan S; Taskin OS
    J Biochem Mol Toxicol; 2021 Jun; 35(6):1-9. PubMed ID: 33704864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro inhibitory effects of some acetophenone derivatives on some metabolic enzymes and molecular docking.
    Taslimi P
    Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000210. PubMed ID: 32876951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4-oxadiazole derivatives: Synthesis, in vitro screening, and computational studies.
    Fatima B; Saleem F; Salar U; Chigurupati S; Felemban SG; Ul-Haq Z; Tariq SS; Almahmoud SA; Taha M; Shah STA; Khan KM
    Arch Pharm (Weinheim); 2023 Dec; 356(12):e2300384. PubMed ID: 37806747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
    Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
    Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, in vitro Α-Glucosidase, and acetylcholinesterase inhibitory activities of novel Indol-Fused Pyrano[2,3-D]Pyrimidine compounds.
    Nguyen HT; Tuan AN; Thi TAD; Van KT; Le-Nhat-Thuy G; Thi PH; Thi QGN; Thi CB; Quang HT; Van Nguyen T
    Bioorg Med Chem Lett; 2024 Jan; 98():129566. PubMed ID: 38008338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phytochemical profiling and in vitro screening for anticholinesterase, antioxidant, antiglucosidase and neuroprotective effect of three traditional medicinal plants for Alzheimer's Disease and Diabetes Mellitus dual therapy.
    Penumala M; Zinka RB; Shaik JB; Mallepalli SKR; Vadde R; Amooru DG
    BMC Complement Altern Med; 2018 Mar; 18(1):77. PubMed ID: 29499679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
    Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An Efficient Synthesis of bi-Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease.
    Rehman TU; Khan IU; Ashraf M; Tarazi H; Riaz S; Yar M
    Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28220522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
    Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, synthesis, in vitro and in silico evaluations of new isatin-triazine- aniline hybrids as potent anti- Alzheimer multi-target directed lead compounds.
    Tamaddon-Abibigloo Y; Dastmalchi S; Razzaghi-Asl N; Shahbazi Mojarrad J
    Bioorg Chem; 2024 Jun; 147():107355. PubMed ID: 38657528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
    Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
    Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
    Gao H; Jiang Y; Zhan J; Sun Y
    Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and molecular docking simulation of new benzimidazole-thiazole hybrids as cholinesterase inhibitors.
    Dawood DH; Srour AM; Omar MA; Farghaly TA; El-Shiekh RA
    Arch Pharm (Weinheim); 2024 Jan; 357(1):e2300201. PubMed ID: 37937360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
    Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
    Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and Synthesis of Novel Dual Cholinesterase Inhibitors: In Vitro Inhibition Studies Supported with Molecular Docking.
    Koca M; Güller U; Güller P; Dağalan Z; Nişancı B
    Chem Biodivers; 2022 Jun; 19(6):e202200015. PubMed ID: 35470963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α-glucosidase enzymes.
    Mohammadi-Khanaposhtani M; Nori M; Valizadeh Y; Javanshir S; Dastyafteh N; Moaazam A; Hosseini S; Larijani B; Adibi H; Biglar M; Hamedifar H; Mahdavi M; Kamci H; Karakus A; Taslimi P
    Arch Pharm (Weinheim); 2022 May; 355(5):e2100313. PubMed ID: 35132681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.